The organometallics market is projected to grow from USD 29.6 billion in 2025 to USD 40.9 billion by 2035, at a CAGR of 3.3%. Organometallic Compounds will dominate with a 46.2% market share, while pharmaceuticals will lead the application segment with a 36.6% share.